Examining Genetic Differences Among People With 21-Hydroxylase Deficiency
Completed · Not applicable
Conditions studied: 21-hydroxylase Deficiency
In brief
Congenital adrenal hyperplasia (CAH) is a genetic disorder that affects the amount of steroids that the body forms. The most common form of CAH is 21-hydroxylase deficiency (21OHD), which leads to cortisol deficiency. This, in turn, causes the development of mature masculine characteristics in newborn, prepubescent, and grown females and in prepubescent males. 21OHD is known to be caused by the mutation of a specific gene. However, symptom severity among people with 21OHD varies, and adults seem to be less affected than children. This study will examine participants' DNA to determine what other genes may affect the severity of 21OHD and may make the disease milder in adults than in children.
Key facts
- Study ID
- NCT00542841
- Run by
- Maria I. New
- People needed
- 99
- Starts
- 2007-08-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2015-12-14
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of 21OHD with two "severe" alleles, excluding the A/C656G mutation OR participant consents to genetic testing and a CYP21A2 mutation is identified
- Currently a patient at one of the participating centers
- Currently taking less than 15mg/m² hydrocortisone per day and has been for at least the past 3 months
You may not qualify if…
- History of adrenal crisis within 1 year prior to study entry
- Any coexisting condition requiring corticosteroid therapy (e.g., asthma, psoriasis)
- History of removal of both adrenal glands
- History of deficient pituitary gland function
- Current or past use of growth hormone therapy within 3 months prior to study entry
- Serum creatinine level greater than 2 mg/dL
- Systolic blood pressure less than 90 mm Hg
- History of critical illness or surgery that required general anesthesia within 1 month prior to study entry
Where it is running
- Mount Sinai School of Medicine — New York, New York, United States
- University of Texas Southwestern Medical Center — Dallas, Texas, United States
- University of Sao Paolo — São Paulo, São Paulo, Brazil
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.